In a rare example of a university tec transfer deal attracting an upfront payment, French pharma company Ipsen paying €1.25 million for a treatment licence.
A shortage of later stage projects is forcing companies hunt further down the drug discovery ladder. Now the Wellcome Trust is injecting charitable money to fill the holes.
The Czech Republic has capped off a series of investments by US software companies with the news that Red Hat is to set up a development centre in Brno.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.